660 Results

People

  1. Riely
    Riely
  2. Perales
    Perales
  3. Abu-Rustum
    Abu-Rustum
  4. Barker
    Barker
  5. Akin
    Akin
  6. Eastham
    Eastham
  7. Horwitz
    Horwitz
  8. Papanicolaou
    Papanicolaou
  9. Saltz
    Saltz
  10. Bodei
    Bodei

Groups

  1. Department of Medicine (285)
  2. Solid Tumor Oncology Division (154)
  3. Surgery (125)
  4. Hematologic Malignancies, Division of (86)
  5. Survivorship Research (85)
  6. Center for Hematologic Malignancies (80)
  7. Radiology, Department of (76)
  8. Division of Subspecialty Medicine (69)
  9. Population Sciences Research Program (59)
  10. Radiation Oncology, Department of (55)
  1. "Guidelines"
Formats
  1. Guidelines (660)
Groups
  1. Department of Medicine (285)
  2. Solid Tumor Oncology Division (154)
  3. Surgery (125)
  4. Hematologic Malignancies, Division of (86)
  5. Survivorship Research (85)
  6. Center for Hematologic Malignancies (80)

More Groups

People
  1. Gregory Riely (14)
  2. Miguel-Angel Perales (12)
  3. Christopher Barker (11)
  4. Nadeem Abu-Rustum (11)
  5. Genovefa Papanicolaou (10)
  6. James Eastham (10)

More People

Years
  1. 2025 (36)
  2. 2024 (90)
  3. 2023 (97)
  4. 2022 (112)
  5. 2021 (103)
  6. 2020 (114)

More Years

Publications
  1. Journal of the National Comprehensive Cancer Network (149)
  2. Journal of Clinical Oncology (53)
  3. Transplantation and Cellular Therapy (31)
  4. Journal of the American College of Radiology (26)
  5. Annals of Oncology (20)
  6. Journal for ImmunoTherapy of Cancer (20)

More Publications

Publishers
  1. Harborside Press (149)
  2. Elsevier Inc. (82)
  3. Elsevier Science, Inc. (79)
  4. American Society of Clinical Oncology (60)
  5. Oxford University Press (36)
  6. Lippincott Williams & Wilkins (32)

More Publishers

Results (660)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment
    Guidelines

    Shonka, D. C. Jr; Ho, A.; Chintakuntlawar, A. V.; Geiger, J. L.; Park, J. C.; Seetharamu, N.; Jasim, S.; Abdelhamid Ahmed, A. H.; Bible, K. C.; Brose, M. S.; more...
    Head & Neck (2022)

    Fulltext@MSK | Save
  • ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer
    Guidelines

    Passaro, A.; Leighl, N.; Blackhall, F.; Popat, S.; Kerr, K.; Ahn, M. J.; Arcila, M. E.; Arrieta, O.; Planchard, D.; de Marinis, F.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults
    Guidelines

    Goyal, G.; Tazi, A.; Go, R. S.; Rech, K. L.; Picarsic, J. L.; Vassallo, R.; Young, J. R.; Cox, C. W.; Van Laar, J.; Hermiston, M. L.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • ACR-ACNM-ASTRO-SNMMI practice parameter for Lutetium-177 (Lu-177) DOTATATE therapy
    Guidelines

    Love, C.; Desai, N. B.; Abraham, T.; Banks, K. P.; Bodei, L.; Boike, T.; Brown, R. K. J.; Bushnell, D. L.; DeBlanche, L. E.; Dominello, M. M.; more...
    Clinical Nuclear Medicine (2022)

    Fulltext@MSK | Save
  • NCCN Guidelines® Insights: Hodgkin lymphoma, version 2.2022: Featured updates to the NCCN Guidelines
    Guidelines

    Hoppe, R. T.; Advani, R. H.; Ai, W. Z.; Ambinder, R. F.; Armand, P.; Bello, C. M.; Benitez, C. M.; Chen, W.; Dabaja, B.; Daly, M. E.; more...
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • Management of immunotherapy-related toxicities, version 1.2022: NCCN Clinical Practice Guidelines in Oncology
    Guidelines

    Thompson, J. A.; Schneider, B. J.; Brahmer, J.; Achufusi, A.; Armand, P.; Berkenstock, M. K.; Bhatia, S.; Budde, L. E.; Chokshi, S.; Davies, M.; more...
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • Considerations on integrating prostate-specific membrane antigen positron emission tomography imaging into clinical prostate cancer trials by National Clinical Trials Network Cooperative Groups
    Guidelines

    Schöder, H.; Hope, T. A.; Knopp, M.; Kelly, W. K.; Michalski, J. M.; Lerner, S. P.; Tawab-Amiri, A.; Mann, B. S.; Lin, D. W.; Yu, E. Y.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Molecular pathology education: A suggested framework for primary care resident training in genomic medicine: A report of the Association for Molecular Pathology Training and Education Committee
    Guidelines

    Arcila, M. E.; Snow, A. N.; Akkari, Y. M. N.; Chabot-Richards, D.; Pancholi, P.; Tafe, L. J.
    Journal of Molecular Diagnostics (2022)

    Fulltext@MSK | Save
  • ACR Appropriateness Criteria® Staging and Surveillance of Testicular Cancer: 2021 update
    Guidelines

    Schieda, N.; Oto, A.; Allen, B. C.; Akin, O.; Barker, S. J.; Fulgham, P. F.; Gettle, L. M.; Maranchie, J. K.; Patel, B. N.; Schuster, D. M.; more...
    Journal of the American College of Radiology (2022)

    Fulltext@MSK | Save
  • NCCN Guidelines® Insights: Hematopoietic growth factors, version 1.2022: Featured updates to the NCCN Guidelines
    Guidelines

    Griffiths, E. A.; Roy, V.; Alwan, L.; Bachiashvili, K.; Baird, J.; Cool, R.; Dinner, S.; Geyer, M.; Glaspy, J.; Gojo, I.; more...
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save